66 related articles for article (PubMed ID: 27115175)
41. Linking of Antitumor trans NHC-Pt(II) Complexes to G-Quadruplex DNA Ligand for Telomeric Targeting.
Betzer JF; Nuter F; Chtchigrovsky M; Hamon F; Kellermann G; Ali S; Calméjane MA; Roque S; Poupon J; Cresteil T; Teulade-Fichou MP; Marinetti A; Bombard S
Bioconjug Chem; 2016 Jun; 27(6):1456-70. PubMed ID: 27115175
[TBL] [Abstract][Full Text] [Related]
42. Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies.
Islam MK; Jackson PJ; Rahman KM; Thurston DE
Future Med Chem; 2016 Jul; 8(11):1259-90. PubMed ID: 27442231
[TBL] [Abstract][Full Text] [Related]
43. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
[TBL] [Abstract][Full Text] [Related]
44. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Jain AK; Bhattacharya S
Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
[TBL] [Abstract][Full Text] [Related]
45. Methods of studying telomere damage induced by quadruplex-ligand complexes.
Rizzo A; Salvati E; Biroccio A
Methods; 2012 May; 57(1):93-9. PubMed ID: 22410593
[TBL] [Abstract][Full Text] [Related]
46. G-quadruplexes as therapeutic targets.
Neidle S; Read MA
Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
[TBL] [Abstract][Full Text] [Related]
47. Novel anticancer strategy aimed at targeting shelterin complexes by the induction of structural changes in telomeric DNA: hitting two birds with one stone.
Bidzinska J; Baginski M; Skladanowski A
Curr Cancer Drug Targets; 2014; 14(2):201-16. PubMed ID: 24443969
[TBL] [Abstract][Full Text] [Related]
48. Stabilisation of G-quadruplex DNA by small molecules.
Arola A; Vilar R
Curr Top Med Chem; 2008; 8(15):1405-15. PubMed ID: 18991726
[TBL] [Abstract][Full Text] [Related]
49. Metal-Organic Compounds as Anticancer Agents: Versatile Building Blocks for Selective Action on G-quadruplexes.
Toro PM; Saldias M; Valenzuela-Barra G
Curr Med Chem; 2023; 30(5):573-600. PubMed ID: 35670351
[TBL] [Abstract][Full Text] [Related]
50. Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules.
Francisco AP; Paulo A
Curr Med Chem; 2017; 24(42):4873-4904. PubMed ID: 27573064
[TBL] [Abstract][Full Text] [Related]
51. Promise of G-Quadruplex Structure Binding Ligands as Epigenetic Modifiers with Anti-Cancer Effects.
Sengupta A; Ganguly A; Chowdhury S
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736345
[TBL] [Abstract][Full Text] [Related]
52. Telomeric G-quadruplex architecture and interactions with potential drugs.
Sissi C; Palumbo M
Curr Pharm Des; 2014; 20(41):6489-509. PubMed ID: 24975609
[TBL] [Abstract][Full Text] [Related]
53. Design of selective G-quadruplex ligands as potential anticancer agents.
Tan JH; Gu LQ; Wu JY
Mini Rev Med Chem; 2008 Oct; 8(11):1163-78. PubMed ID: 18855731
[TBL] [Abstract][Full Text] [Related]
54. G-quadruplex in cancer biology and drug discovery.
Nakanishi C; Seimiya H
Biochem Biophys Res Commun; 2020 Oct; 531(1):45-50. PubMed ID: 32312519
[TBL] [Abstract][Full Text] [Related]
55. Telomeres expand sphere of influence: emerging molecular impact of telomeres in non-telomeric functions.
Vinayagamurthy S; Bagri S; Mergny JL; Chowdhury S
Trends Genet; 2023 Jan; 39(1):59-73. PubMed ID: 36404192
[TBL] [Abstract][Full Text] [Related]
56. Design of Modular G-quadruplex Ligands.
Duarte AR; Cadoni E; Ressurreição AS; Moreira R; Paulo A
ChemMedChem; 2018 May; 13(9):869-893. PubMed ID: 29512884
[TBL] [Abstract][Full Text] [Related]
57. On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents.
Alessandrini I; Recagni M; Zaffaroni N; Folini M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073075
[TBL] [Abstract][Full Text] [Related]
58. G-quadruplexes: a promising target for cancer therapy.
Kosiol N; Juranek S; Brossart P; Heine A; Paeschke K
Mol Cancer; 2021 Feb; 20(1):40. PubMed ID: 33632214
[TBL] [Abstract][Full Text] [Related]
59. A Fluorescent Anti-Cancer Agent, 3,6-bis(1-methyl-4-vinylpyridinium) Carbazole Diiodide, Stains G-Quadruplexes in Cells and Inhibits Tumor Growth.
Tse TY; Chang CC; Lin JJ; Chang TC
Curr Top Med Chem; 2015; 15(19):1964-70. PubMed ID: 25980413
[TBL] [Abstract][Full Text] [Related]
60. Bioactive nutraceuticals as G4 stabilizers: potential cancer prevention and therapy-a critical review.
Choudhury SD; Kumar P; Choudhury D
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3585-3616. PubMed ID: 38019298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
